0000874015-17-000013.txt : 20170118
0000874015-17-000013.hdr.sgml : 20170118
20170118183645
ACCESSION NUMBER: 0000874015-17-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170115
FILED AS OF DATE: 20170118
DATE AS OF CHANGE: 20170118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CROOKE STANLEY T
CENTRAL INDEX KEY: 0000897667
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 17534446
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-01-15
0000874015
IONIS PHARMACEUTICALS INC
IONS
0000897667
CROOKE STANLEY T
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
1
0
0
Chairman and CEO
Common Stock
2017-01-15
2017-01-15
4
M
0
5547
0
A
30576
D
Common Stock
2017-01-17
2017-01-17
4
S
0
3008
46.289
D
27568
D
Common Stock
2017-01-15
2017-01-15
4
M
0
7812
0
A
35380
D
Common Stock
2017-01-17
2017-01-17
4
S
0
4236
46.289
D
31144
D
Common Stock
2017-01-15
2017-01-15
4
M
0
6875
0
A
38019
D
Common Stock
2017-01-17
2017-01-17
4
S
0
3728
46.29
D
34291
D
Common Stock
2017-01-15
2017-01-15
4
M
0
8133
0
A
42424
D
Common Stock
2017-01-17
2017-01-17
4
S
0
4410
46.29
D
38014
D
Common Stock
2017-01-15
2017-01-15
4
M
0
416
0
A
2586
I
By wife
Common Stock
2017-01-17
2017-01-17
4
S
0
163
46.291
D
2423
I
By wife
Common Stock
2017-01-15
2017-01-15
4
M
0
354
0
A
2777
I
By wife
Common Stock
2017-01-17
2017-01-17
4
S
0
139
46.29
D
2638
I
By wife
Common Stock
2017-01-15
2017-01-15
4
M
0
363
0
A
3001
I
By wife
Common Stock
2017-01-17
2017-01-17
4
S
0
142
46.291
D
2859
I
By wife
Common Stock
2017-01-15
2017-01-15
4
M
0
334
0
A
3193
I
By wife
Common Stock
2017-01-17
2017-01-17
4
S
0
131
46.29
D
3062
I
By wife
Common Stock
725391
I
By trust
Restricted Stock Units
2017-01-15
2017-01-15
4
A
0
27168
0
A
Common Stock
27168
27168
D
Restricted Stock Units
2017-01-15
2017-01-15
4
A
0
2692
0
A
Common Stock
2692
2692
I
By wife
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
5547
0
D
Common Stock
5547
0
D
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
7812
0
D
Common Stock
7812
7812
D
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
6875
0
D
Common Stock
6875
13750
D
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
8133
0
D
Common Stock
8133
24397
D
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
416
0
D
Common Stock
416
0
I
By wife
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
354
0
D
Common Stock
354
354
I
By wife
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
363
0
D
Common Stock
363
724
I
By wife
Restricted Stock Units
2017-01-15
2017-01-15
4
M
0
334
0
D
Common Stock
334
999
I
By wife
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 30, 2013.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 30, 2013.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2014.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2014.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2015.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2015.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2016.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2016.
Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2013.
The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2013.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Grant 1/15/2017 to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
Grant 1/15/2017 to reporting person's wife of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
/s/B. Lynne Parshall, attorney-in-fact
2017-01-18